The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Open Access
- 1 June 2024
- journal article
- editorial
- Published by Springer Nature in Drugs in R&D
- Vol. 24 (2) , 123-127
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999–2021)Contemporary Clinical Trials, 2022
- Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical ResearchJAMA, 2022
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineAnnals of Oncology, 2022
- Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic reviewSupportive Care in Cancer, 2020
- A review of the barriers to using Patient‐Reported Outcomes (PROs) and Patient‐Reported Outcome Measures (PROMs) in routine cancer careJournal of Medical Radiation Sciences, 2020
- Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core—an adaptive measure of core quality of life domains in oncology clinical practice and researchJournal of Clinical Epidemiology, 2020
- Making a picture worth a thousand numbers: recommendations for graphically displaying patient-reported outcomes dataQuality of Life Research, 2018
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial ProtocolsJAMA, 2018
- Reporting of Patient-Reported Outcomes in Randomized TrialsJAMA, 2013
- The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessmentQuality of Life Research, 2007